Quarterly report pursuant to Section 13 or 15(d)

CONSOLIDATED BALANCE SHEETS

v3.2.0.727
CONSOLIDATED BALANCE SHEETS - USD ($)
Jun. 30, 2015
Dec. 31, 2014
Current assets    
Cash $ 80 $ 623
Total current assets 80 623
Fixed assets - net 85 454
Total Assets 165 1,077
Current liabilities    
Accounts payable 571,517 484,260
Accrued interest payable 484,047 407,684
Notes payable - current - related parties 697,225 697,225
Notes payable - current, net 908,219 871,694
Notes payable - derivitive liability payable 0 25,456
Stock subscription payable 28,067 28,067
Related party payables 355,765 296,265
Other payables 241,915 241,922
Total current liabilities 3,286,755 3,052,573
Notes payable - related parties 43,298 43,298
Total Liabilities 3,330,053 3,095,871
Stockholders' Deficit    
Common stock, $.00001 par value; 100,000,000 shares authorized; 59,251,068 and 58,416,660 shares issued and outstanding as of June 30, 2015 and December 31, 2014, respectively 592 585
Additional paid in capital 12,768,956 12,716,630
Accumulated deficit (16,062,782) (15,777,222)
Total Transbiotec, Inc. stockholders' deficit (3,293,234) (3,060,007)
Noncontrolling interest (36,654) (34,787)
Total Stockholders' Deficit (3,329,888) (3,094,794)
Total Liabilities and Stockholders' Deficit $ 165 $ 1,077